short acting glp 1 agonists glp-1_analogs [TUSOM Frontiers | GLP−1 receptor agonists
Description
The 2022 New England Journal of Medicine study showing effectiveness of Wegovy at preventing Major Adverse Cardiovascular Events (MACE) required 100 people to be treated for 3 years to prevent one MACE event
The gastrointestinal side effect profile is similar but not identical
16 ) and mGIPR-Ab/P3 (ref
Recent media reports and emerging research have raised concerns about potential links between GLP-1 medications and certain eye conditions, particularly diabetic retinopathy a complication of diabetes that can lead to vision loss if left untreated
2022;257 doi: 10.1016/j.physbeh.2022.113967
